With a market cap of $10.4 billion, Jack Henry & Associates, Inc. (JKHY) is a financial technology company that connects people and financial institutions through technology solutions and payment processing services. It operates through four segments: Core, Payments, Complementary, and Corporate and Other, offering platforms and services ranging from core banking systems and digital/mobile banking to payment processing, risk management, and hardware solutions.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Jack Henry & Associates fits this criterion perfectly. The company provides a range of products including SilverLake, Symitar, CIF 20/20, Core Director, and the Banno Digital Platform.
Shares of the Monett, Missouri-based company have dipped 23.3% from its 52-week high of $193.39. Over the past three months, the stock has increased 18.4%, outpacing the Dow Jones Industrial Average's ($DOWI) marginal decline during the same period.
Shares of the financial technology firm have fallen 18.7% on a YTD basis, underperforming DOWI’s 7.2% return. Moreover, the stock has declined 1.1% over the past 52 weeks, compared to DOWI's 11.3% gain over the same time frame.
Yet, JKHY stock has been trading above its 50-day and 200-day moving averages since late June.
Jack Henry & Associates shares climbed 6.5% following its Q4 2026 results on Aug. 18, with better-than-expected EPS of $1.57 and revenue of approximately $644 million. Growth was supported by strong demand for its banking and payments technology, with services and support revenue up 2.5% and processing revenue up 7.5%, while management highlighted a robust sales pipeline and continued adoption of AI-driven solutions.
In comparison, rival Accenture plc (ACN) has lagged behind JKHY stock. ACN stock has decreased 31.6% on a YTD basis and 22.1% over the past 52 weeks.
Despite the stock’s underperformance relative to the Dow over the past year, analysts are cautiously optimistic about its prospects. JKHY stock has a consensus rating of “Moderate Buy” from the 20 analysts covering it, and the mean price target of $188 is a premium of 26.7% to current levels.